Author:
Lindenberg Liza,Choyke Peter,Dahut William
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Ferlay J, S.I., Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. 2013. Available from: http://globocan.iarc.fr 3/20/2014].
2. Hillner BE et al. Impact of F-18-fluoride PET in patients with known prostate cancer: initial results from the National Oncologic PET Registry. J Nucl Med. 2014;55(4):574–81.
3. Hillner BE et al. 18F-fluoride PET used for treatment monitoring of systemic cancer therapy: results from the National Oncologic PET Registry. J Nucl Med. 2015;56(2):222–8.
4. Sampath SC et al. Detection of osseous metastasis by F-18-NaF/F-18-FDG PET/CT versus CT alone. Clin Nucl Med. 2015;40(3):E173–7.
5. Simoncic U et al. Comparison of NaF and FDG PET/CT for assessment of treatment response in castration-resistant prostate cancers with osseous metastases. Clin Genitourin Cancer. 2015;13(1):E7–17.
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献